GILEAD SCIENCES, INC. — Director's Dealing 2013

Feb 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-02-01

Reporting Person: YOUNG KEVIN (EVP, Commercial Operations)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-01	Non-Qualified Stock Optin (right to buy)	$40.56	A	108470	Disposed	2023-02-01	Common Stock (108470)	Direct

Footnotes

F1: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.